Skip to content

Endometrial Polyp Treatment

Endometrial polyp treatment options explained: watchful waiting, hormonal management, and hysteroscopic polypectomy. Expert, incision-free polyp removal on the Upper East Side.

Header image for Uterine Endometrial Polyp Treatment

Endometrial Polyp Treatment in New York City

A diagnosis of endometrial polyps can raise a lot of questions. Do they need to come out? Will they affect my ability to get pregnant? What does the procedure involve? How soon can I return to normal?

The answers depend on factors specific to you: your symptoms, your fertility goals, the size and character of the polyp, and whether you are pre- or postmenopausal. Fortunately, treatment options are well-established, minimally invasive, and, in most cases, straightforward.

Considerations Before Endometrial Polyp Treatment

Not every endometrial polyp requires immediate removal. Before recommending any specific course of action, a gynecologist will consider several factors.

Symptoms

Polyps that are causing abnormal uterine bleeding, heavy or irregular periods, bleeding between cycles, or postmenopausal spotting generally warrant treatment rather than continued observation. Asymptomatic polyps, discovered incidentally during an ultrasound or evaluation for another concern, may be candidates for watchful waiting, depending on other factors.

Size

Larger polyps are less likely to resolve on their own and more likely to cause symptoms and carry a higher risk of abnormal pathology. Small polyps under 10 millimeters in diameter in asymptomatic premenopausal women have a documented rate of spontaneous regression, though this is not reliable enough to apply universally. Larger polyps, generally those above 1 centimeter, and particularly those above 2 to 3 centimeters, are more consistently recommended for removal.

Risk Factors for Malignancy

The overall risk that a benign-appearing endometrial polyp contains precancerous or cancerous cells is low: approximately 2.73 percent across all women in a large systematic review. However, that risk is not uniform. It is lower in premenopausal women (approximately 1 percent) and higher in postmenopausal women (approximately 5 percent). Risk rises further in women with abnormal uterine bleeding, obesity, diabetes, hypertension, or a history of tamoxifen use. In postmenopausal women with bleeding, removal and pathological examination are the standard of care.

Fertility Status and Goals

Women who are trying to conceive, planning IVF, or experiencing unexplained infertility or implantation failure are routinely recommended for polypectomy before fertility treatment. Endometrial polyps can disrupt the uterine environment in ways that impair embryo implantation, and removal has been consistently shown to improve fertility outcomes.

Menopausal Status

In postmenopausal women, the threshold for removal is lower because the likelihood of spontaneous regression is minimal and the risk of pathological findings is higher.

Depending on these factors, your gynecologist will likely recommend one of the following treatment plans.

Watchful Waiting

For some women, active surveillance without immediate intervention is a clinically appropriate approach.

Watchful waiting is most reasonable for women who are premenopausal, asymptomatic, have a small polyp (typically under 10 millimeters) identified incidentally, and have no significant risk factors for endometrial malignancy.

Research has shown that a subset of small polyps in premenopausal women may regress spontaneously over a period of several months. However, this regression is not predictable, it does not occur reliably in larger polyps, and it does not occur reliably in women who are trying to conceive, where polyps tend to persist without intervention.

What watchful waiting involves:

  • Repeat transvaginal ultrasound at an interval agreed upon with your gynecologist, typically within three to six months
  • Prompt re-evaluation if new symptoms develop, including any abnormal bleeding or changes in cycle pattern
  • A clear escalation plan: if the polyp grows, persists, or new symptoms arise, the appropriate response is removal

Watchful waiting is not appropriate for postmenopausal women with any abnormal bleeding, for women with elevated risk factors for endometrial pathology, or for women who are actively trying to conceive or planning assisted reproductive treatment. In those settings, removal and pathological diagnosis are the recommended courses.

Hormonal Management

Hormonal therapy for endometrial polyps serves two purposes that are worth distinguishing clearly. It can help manage symptoms such as abnormal or heavy bleeding associated with polyps. And it can reduce the risk of polyp recurrence after surgical removal. What it generally does not do is eliminate an existing polyp. There are currently no hormonal medications proven to reliably dissolve established endometrial polyps.

Levonorgestrel-releasing IUD

The levonorgestrel IUD is the hormonal option with the most robust evidence for endometrial polyp-related management. It delivers progestin locally to the uterine cavity, suppressing the estrogen-driven endometrial proliferation that contributes to polyp formation and recurrence.

A meta-analysis of 19 randomized controlled trials found that the LNG-IUS was more effective than oral progestin at preventing polyp recurrence after hysteroscopic removal, while also producing fewer side effects. It is particularly well-suited for women who have had one or more polyps removed and want to reduce the likelihood of recurrence, and for women who also have adenomyosis, given its additional benefit in reducing adenomyosis-related bleeding.

The LNG-IUS is not appropriate for women who are actively trying to conceive, as it functions as a contraceptive. It is also not a substitute for removal when tissue diagnosis is needed.

Oral Progestins

Progestin-only pills or cyclic progesterone can help reduce endometrial thickness and manage abnormal bleeding. Evidence supports their use as a secondary preventive option after polypectomy when the LNG-IUS is not suitable. Their effect on existing polyps is limited, and they are not a definitive treatment.

Combined Oral Contraceptives

Combined oral contraceptives may help reduce abnormal bleeding associated with polyps and may modestly reduce the risk of new polyp formation by suppressing endometrial proliferation. Like progestins, they do not reliably shrink or resolve an established polyp.

Hysteroscopic Polypectomy

Hysteroscopic polypectomy is the definitive treatment for endometrial polyps and the approach recommended for all symptomatic polyps, polyps in higher-risk patients, polyps being evaluated before fertility treatment, and any polyp requiring tissue diagnosis.

It is, importantly, a procedure that causes no abdominal incisions. It is performed entirely through the natural opening of the cervix, using a thin, lighted instrument called a hysteroscope. Most women go home the same day and return to normal activities within 24 to 48 hours.

What the Procedure Involves

Hysteroscopic polypectomy is performed as an outpatient procedure, either in an office-based surgical suite or an outpatient surgical center, under local anesthesia with sedation or under light general anesthesia depending on the patient’s preferences, anxiety level, and the complexity of the case.

The hysteroscope is passed gently through the vagina and cervix into the uterine cavity, which is expanded with saline solution to allow clear visualization. The gynecologist views the uterine cavity directly on a monitor, identifies the polyp, and removes it using specialized instruments such as a resectoscope or a tissue removal device. The procedure typically takes between 15 and 45 minutes, depending on the size and number of polyps.

All removed tissue is sent to a pathology laboratory for examination. This is a non-negotiable part of the procedure: pathological analysis is what confirms whether the polyp is benign, contains atypical cells (precancerous changes), or, in rare cases, is malignant. The result typically returns within one to two weeks.

What to Expect After the Procedure

Recovery from hysteroscopic polypectomy is generally brief and well-tolerated.

  • Light spotting or discharge in the days following the procedure is normal
  • Mild cramping, similar to menstrual cramps, may occur for a day or two and typically responds well to over-the-counter pain relief
  • Most women return to desk work and light daily activities within 24 hours
  • Intercourse and tampon use are typically restricted for two weeks to allow the uterine lining to heal
  • A follow-up appointment is scheduled to review pathology results and confirm recovery
  • The first menstrual period following polypectomy typically arrives on schedule or slightly delayed

The Aveta Tissue Removal System

One commonly used instrument for hysteroscopic polypectomy is the Aveta device, which uses a rotating cutting tip to remove polyp tissue in small pieces that are simultaneously suctioned out of the uterine cavity. This approach is particularly efficient for polyps with a broad base or multiple polyps, and it reduces the risk of leaving residual tissue behind.

Other approaches include using a resectoscope with an electrosurgical loop to excise the polyp at its stalk, or mechanical grasping forceps for smaller, pedunculated polyps.

Endometrial Polyp Treatment and Fertility

For women who are trying to conceive, endometrial polyps deserve specific attention. The research is consistent: endometrial polyps can impair embryo implantation, and their removal before trying to conceive improves outcomes.

How Do Polyps Affect Fertility

Polyps can interfere with fertility through several mechanisms. They alter the architecture of the uterine cavity, creating an abnormal surface for embryo implantation. They generate a local inflammatory environment with elevated cytokines that may be hostile to an embryo. They can mechanically obstruct the fallopian tube openings. And they may affect the hormonal and molecular signals that regulate endometrial receptivity.

Evidence Supporting Removal Before IVF

A 2024 study published in the Journal of Clinical Medicine found that after hysteroscopic polypectomy in women with unexplained infertility and at least one prior failed IVF attempt, 72.5 percent achieved a positive pregnancy result in the subsequent cycle. A 2026 review of IVF/ICSI outcomes found clinical pregnancy rates of 53 to 72 percent and live birth rates of 43 to 66 percent following polypectomy in women with documented polyps.

Current clinical guidance, including the 2024 SOGC guideline, favors polypectomy before IVF for symptomatic polyps and those meeting specific clinical criteria. For most women undergoing IVF evaluation, if a polyp is identified on ultrasound or saline infusion sonography, removal before proceeding with embryo transfer is the standard approach.

When to Get Polypectomy If Receiving Fertility Treatment

Hysteroscopic polypectomy is typically performed in the cycle before planned fertility treatment, allowing the uterine lining adequate time to heal before embryo transfer. Your gynecologist and reproductive endocrinologist will coordinate on timing when both are involved in your care.

Endometrial Polyp Treatment in Postmenopausal Women

In postmenopausal women, the evaluation and treatment of endometrial polyps follows a more consistently interventional path. The reasons are straightforward.

First, postmenopausal endometrial polyps do not resolve spontaneously. The hormonal environment that sometimes drives regression in younger women is no longer present.

Second, the risk of precancerous or cancerous findings within a polyp is meaningfully higher in postmenopausal women, particularly those with abnormal uterine bleeding. Research shows the risk of malignant findings is approximately 5 percent in postmenopausal women overall, rising significantly in those who have any bleeding.

Third, any postmenopausal bleeding requires thorough evaluation, and the removal and pathological examination of any identified polyp is part of that evaluation.

For postmenopausal women who are asymptomatic and whose polyp is identified incidentally, the decision about whether to remove it may be individualized based on size, imaging features, and overall health, in discussion with a specialist. However, watchful waiting in a postmenopausal woman with any bleeding is not the standard of care.

Can Uterine Polyps Recur?

Even after successful removal, endometrial polyps can recur. Reported recurrence rates vary widely in the literature, ranging from approximately 2.5 to 3.7 percent for straightforward cases to 20 to 40 percent in higher-risk groups, including women with multiple polyps, long-term tamoxifen use, or other risk factors.

The LNG-IUS is the most evidence-supported strategy for reducing recurrence after polypectomy. Oral progestins are a secondary option. Continued monitoring with periodic ultrasound is part of follow-up care for women at higher risk of recurrence.

Endometrial Polyp Treatment at Kim Gyn

At KimGyn, every endometrial polyp evaluation begins with a thorough conversation. Dr. Annie Kim takes the time to understand your full history, your symptoms, your fertility goals, and any concerns you have about the procedure before recommending a course of action.

For women who need polypectomy, the procedure is performed with a meticulous, minimally invasive approach, with all tissue sent for pathological analysis as a standard part of care. Dr. Kim reviews your results directly with you and discusses what they mean for your ongoing gynecologic health and your future plans.

Serving patients on the Upper East Side of Manhattan, Kim Gyn offers the kind of unhurried, expert-led gynecologic care that is rare in a city where appointments are often rushed and decisions are often delegated. If you have been diagnosed with an endometrial polyp, or if you are experiencing abnormal bleeding and want to understand what is behind it, a consultation is the right first step.

Schedule a consultation today!

Frequently Asked Questions About Endometrial Polyp Treatment

Is hysteroscopic polypectomy painful?

The procedure itself is performed under anesthesia, so discomfort during the procedure is minimal. Afterward, most women experience mild cramping similar to period cramps for one to two days. The vast majority of patients find the recovery comfortable and manageable with over-the-counter pain relief.

Can a polyp come back after removal?

Yes. Polyp recurrence is possible, particularly in women with multiple polyps, hormonal imbalances, or other risk factors. The LNG-IUS placed after removal is the most evidence-supported strategy for reducing recurrence risk. Regular ultrasound monitoring is typically recommended during follow-up.

Can endometrial polyps cause infertility?

Yes. Polyps can impair embryo implantation and reduce the likelihood of natural and assisted conception. Research consistently shows that hysteroscopic polypectomy improves pregnancy outcomes, particularly for women undergoing IVF after prior failed cycles.

How soon can I try to conceive after polypectomy?

Most gynecologists recommend waiting one full menstrual cycle after polypectomy before trying to conceive, to allow the uterine lining to fully heal. In the context of IVF, the procedure is typically planned in the cycle before embryo transfer. Your physician will advise you on the appropriate interval based on your specific circumstances.

Take the first step.

Schedule a consultation with Dr. Kim today.

Book Appointment